Low Tumor miR-369-3p Levels Combined with Plasma Hepatitis B Virus Pre-S2 Gene Deletion Mutation Predict Higher Hepatocellular Carcinoma Recurrence
Ya-Chi Wu, Long-Bin Jeng, Tsai-Chung Li, John Wang, Chiao-Fang Teng · 2026
Read Low Tumor miR-369-3p Levels Combined with Plasma Hepatitis B Virus Pre-S2 Gene Deletion Mutation Predict Higher Hepatocellular Carcinoma Recurrence by Ya-Chi Wu, Long-Bin Jeng, Tsai-Chung Li, John Wang, Chiao-Fang Teng (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13265001.txt.
Description
Ya-Chi Wu and colleagues wrote a 2026 study on predicting liver cancer return after surgery in patients with hepatitis B. Two markers were combined: a deletion flaw in the virus's pre-S2 gene, known to flag recurrence, and a tiny RNA in the tumor called miR-369-3p. The team looked for RNAs tied to both the virus flaw and recurrence.
They found miR-369-3p was lower in tumors of patients who carried the virus deletion or whose cancer returned. Low levels alone flagged higher recurrence risk. Patients with both the deletion and low RNA levels faced higher risk than those with either marker or none. The pair together predicted recurrence better than either alone. The authors call the combined marker exploratory and promising for guiding follow-up after curative surgery.
Catalog record
| CREATOR | Ya-Chi Wu, Long-Bin Jeng, Tsai-Chung Li, John Wang, Chiao-Fang Teng |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 70487 |
| LICENSE | https://creativecommons.org/licenses/by/4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |